Tumor location determines tissue-specific recruitment of tumor-associated macrophages and antibody-dependent immunotherapy response. (Q40103834)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

title

Tumor location determines tissue-specific recruitment of tumor-associated macrophages and antibody-dependent immunotherapy response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Diana Dudziak

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

13

Falk Nimmerjahn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

author name string

Birgit Lehmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Christin Brückner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Andrea Ipsen-Escobedo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Sina Gordan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Christian Lehmann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

David Voehringer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Thomas Winkler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Niels Schaft

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Horia Sirbu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Georg F Weber

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

publication date

1 January 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures

26 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Innate and adaptive immune cells in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Immune cell promotion of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Tumor-associated macrophages: from mechanisms to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

PD-1 blockage delays murine squamous cell carcinoma development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Targeting tumor-associated macrophages in cancer therapy and understanding their complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

The cellular and molecular origin of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Patrolling monocytes control tumor metastasis to the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Renaissance of cancer therapeutic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Immunostimulatory monoclonal antibodies for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Type I and type II Fc receptors regulate innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Complement: help or hindrance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

How immunoglobulin G antibodies kill target cells: revisiting an old paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Neutrophils mediate antibody-induced antitumor effects in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Experimental Antibody Therapy of Liver Metastases Reveals Functional Redundancy between Fc RI and Fc RIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Macrophages eliminate circulating tumor cells after monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Development of monocytes, macrophages, and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

The macrophage: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Origin, development, and homeostasis of tissue-resident macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Origin and functions of tissue macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

A lineage of myeloid cells independent of Myb and hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Divergent immunoglobulin g subclass activity through selective Fc receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Alveolar macrophages: plasticity in a tissue-specific context

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Macrophages and cancer: from mechanisms to therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Inflammatory monocytes and Fcγ receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Origins of tumor-associated macrophages and neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Cutting edge: FcγRIII (CD16) and FcγRI (CD64) are responsible for anti-glycoprotein 75 monoclonal antibody TA99 therapy for experimental metastatic B16 melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Fc receptors are required in passive and active immunity to melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

Repression of Id2 expression by Gfi-1 is required for B-cell and myeloid development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIIMMUNOL.AAH6413

10.1126/SCIIMMUNOL.AAH6413

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28783667%20AND%20SRC:MED&resulttype=core&format=json

release_oavgwv535vhqxiqg7t2fbebcye

26 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oavgwv535vhqxiqg7t2fbebcye

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference